Prostate Cancer
Recent Abstracts
The PRIMARY Score: Diagnostic Performance and Added Value Compared With MRI in Detecting Clinically Significant Prostate Cancer.
December 15, 2023
Engaging communities to inform the development of a diverse cohort of cancer survivors: formative research for the eat move sleep study (EMOVES).
December 14, 2023
Prostate Cancer Risk Stratification Using Magnetic Resonance Imaging-Ultrasound Fusion versus Systematic Prostate Biopsy.
December 14, 2023
Prostate Volume is A Predictor of Gleason Score Upgrading after Radical Prostatectomy in Low-Risk Prostate Cancer: A Systematic Review and Meta-analysis.
December 14, 2023
Network connectivity between psychological resilience and depression in prostate cancer patients.
December 14, 2023
Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate Cancer in a National Health Care Delivery System.
December 14, 2023
Climate change perception and its association with cancer screening intent.
December 14, 2023
Inequities in Definitive Treatment for Localized Prostate Cancer Among Those With Clinically Significant Mental Health Disorders.
December 14, 2023
Genomic and epigenomic analysis of plasma cell-free DNA identifies stemness features associated with worse survival in AR -altered lethal prostate cancer.
December 13, 2023
The effects of glycemic index on prostate cancer progression in a xenograft mouse model.
December 13, 2023
Pilot Trial of Streamlined Genetic Education and Traceback Genetic Testing in Prostate Cancer Survivors.
December 13, 2023
The Brazilian national prospective active surveillance (AS) cohort of patients with low-risk prostate cancer in the public health system: vigiaSUS study protocol.
December 13, 2023
Development of Bleeding Artificial Intelligence Detector (BLAIR) System for Robotic Radical Prostatectomy.
December 13, 2023
Trends in Utilization and Medicare Spending on Short-Course Radiotherapy for Breast and Prostate Cancer: An Episode-Based Analysis from 2015-2019.
December 12, 2023
Clinical Outcomes of Enzalutamide in Metastatic Hormone-sensitive Prostate Cancer in Patients Aged <75 and ≥75 Years: ARCHES Post Hoc Analysis.
December 12, 2023
Post Hoc Analysis of Rapid and Deep Prostate-specific Antigen Decline and Patient-reported Health-related Quality of Life in SPARTAN and TITAN Patients with Advanced Prostate Cancer.
December 12, 2023
Is ultra-hypofractionated whole pelvis radiotherapy (WPRT) as well tolerated as conventionally fractionated WPRT in prostate cancer patients? Early results from the HOPE Trial.
December 12, 2023
Targeting Metabolic Vulnerabilities to Overcome Prostate Cancer Resistance: Dual Therapy with Apalutamide and Complex I Inhibition.
December 12, 2023
Incidental prostate cancer diagnosis is common after holmium laser enucleation of the prostate.
December 11, 2023
Evaluation of the Reliability and the Performance of Magnetic Resonance Imaging Radiomics in the Presence of Randomly Generated Irrelevant Features for Prostate Cancer.
December 11, 2023
Page 62 of 1414
Start
Prev
57
58
59
60
61
62
63
64
65
66
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free